Entera Bio Ltd. (ENTX) Q4 2020 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Entera Bio Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:03.751 Good morning and welcome to Interra's BIOS conference call to discuss the financial and 00:00:03.751 -- 00:00:06.252 operating results for the year end of December 31, 2020. 00:00:06.252 -- 00:00:10.174 At this time, all participants are in a listen-only mode. 00:00:10.174 -- 00:00:13.255 After the speaker's presentation, there will be a question and answer session. 00:00:13.255 -- 00:00:16.817 To ask a question during the session, you'll need to press star 1 on your telephone. 00:00:16.817 -- 00:00:20.058 If you require any further assistance, please press star then 0. 00:00:20.058 -- 00:00:23.520 I would now like to turn the call over to John Lieber, the U.S.-based CFO of Interra. 00:00:23.520 -- 00:00:25.920 Please go ahead. 00:00:32.910 -- 00:00:38.212 Thank you, and welcome to the call. Joining me on today's call are Spiro Jamas, 00:00:38.212 -- 00:00:39.913 our CEO, 00:00:39.913 -- 00:00:44.375 Art Santora, our CMO, and Philip Schwartz, our President of R&D. 00:00:44.375 -- 00:00:47.817 A press release announcing Interra's financial and operating results for the year-end 00:00:47.817 -- 00:00:49.478 of December 31, 2020, 00:00:49.478 -- 00:00:53.780 was issued earlier today. For those of you who have not yet seen it, it is available 00:00:53.780 -- 00:00:58.501 on the investor section of our website, www.interrabio.com. 00:00:59.651 -- 00:01:02.733 On our call this morning, we will share with you a business update and review of our 00:01:02.733 -- 00:01:07.216 financial results, which will be followed by a question and answer session. 00:01:07.216 -- 00:01:10.758 Before we begin our prepared remarks, I would like to remind you that various statements 00:01:10.758 -- 00:01:15.342 we make during this call about the company's fu...